Search results for "PROGNOSIS"

showing 10 items of 2052 documents

Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.

2017

Biological changes that occur during metastatic progression of breast cancer are still incompletely characterized. In this study, we compared intrinsic molecular subtypes and gene expression in 123 paired primary and metastatic tissues from breast cancer patients. Intrinsic subtype was identified using a PAM50 classifier and χ2 tests determined the differences in variable distribution. The rate of subtype conversion was 0% in basal-like tumors, 23.1% in HER2-enriched (HER2-E) tumors, 30.0% in luminal B tumors, and 55.3% in luminal A tumors. In 40.2% of cases, luminal A tumors converted to luminal B tumors, whereas in 14.3% of cases luminal A and B tumors converted to HER2-E tumors. We ident…

Mama -- Càncer -- Aspectes genètics0301 basic medicineCancer ResearchPathologyReceptor ErbB-2DiseaseTranscriptome0302 clinical medicineGene expressionSurvival outcomes Letrozole Concordance Predictor Disease Impact Brain Cells Women RiskSurvival outcomesDiseaseNeoplasm Metastasisskin and connective tissue diseasesRegulation of gene expressionAged 80 and overBrainCells WomenMiddle AgedPrognosisMetastatic breast cancerNeoplasm ProteinsGene Expression Regulation NeoplasticImpactOncology030220 oncology & carcinogenesisLetrozoleFemaleRiskAdultmedicine.medical_specialtymedicine.drug_classBreast NeoplasmsBiologyArticle03 medical and health sciencesBreast cancerConcordancemedicineBiomarkers TumorHumansGeneAgedEstrogensmedicine.disease030104 developmental biologyEstrogenNeoplasm Recurrence LocalTranscriptomePredictor
researchProduct

How can we best organise communication with patients’ families?

2018

IF 1.542 (2016); International audience

Medical educationAudiovisual Aidsbusiness.industryCritical IllnessCommunicationSatisfaction030208 emergency & critical care medicineGeneral MedicineCritical Care and Intensive Care MedicinePrognosis03 medical and health sciencesFamilies0302 clinical medicineAnesthesiology and Pain Medicine030228 respiratory systemMedicineHumansFamilybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease

2021

(1) Background: Neurogranin is a post-synaptic protein expressed in the neurons of the hippocampus and cerebral cortex. It has been recently proposed as a promising biomarker of synaptic dysfunction, especially in Alzheimer’s disease (AD). However, more efforts are needed before introducing it in clinical practice, including the definition of its reference interval (RI). The aim of the study was to establish the RI of cerebrospinal fluid (CSF) neurogranin levels in controls and individuals with non-neurodegenerative neurological diseases; (2) We included a total of 136 individuals that were sub-grouped as follows: AD patients (n = 33), patients with non-neurodegenerative neurological …

Medicine (General)diagnosisClinical BiochemistryneurodegenerationbiomarkersRC3; biomarkers; neurodegeneration; controls; diagnosis; prognosis; tauArticlediagnosiR5-920biomarkercontrolsprognosistaucontrolRC3prognosiDiagnostics
researchProduct

Expression of selected molecular factors in two types of endometrial cancer

2021

BACKGROUND Endometrial cancers (EC) are a heterogeneous group of malignant neoplasms differing in etiology, clinical-pathological features and prognosis. OBJECTIVES To determine the differences between the expression of selected molecular factors and find connections between them in order to isolate possible biomarkers influencing treatment options. MATERIAL AND METHODS The investigated data involved archival histological preparations obtained from uterine EC samples taken from 137 patients, treated surgically between 2007 and 2014. The immunohistochemical Dako EnVisionTM Flex+ method was applied. RESULTS The expression of ERβ, MLH1 and BRCA1 was lower in ECI than in ECII patients. The ERα …

Medicine (miscellaneous)BiologyMLH1General Biochemistry Genetics and Molecular BiologyMYH9AndrologyInternal MedicinemedicineHumansPharmacology (medical)Stage (cooking)Grading (tumors)Genetics (clinical)Neoplasm StagingHeterogeneous groupFAKEndometrial cancerAdvanced stageTreatment optionsBAPPrognosismedicine.diseaseEndometrial Neoplasmsendometrial cancerReviews and References (medical)ImmunohistochemistryFemaleAdvances in Clinical and Experimental Medicine
researchProduct

Machine Learning to Predict In-Hospital Mortality in COVID-19 Patients Using Computed Tomography-Derived Pulmonary and Vascular Features

2021

Pulmonary parenchymal and vascular damage are frequently reported in COVID-19 patients and can be assessed with unenhanced chest computed tomography (CT), widely used as a triaging exam. Integrating clinical data, chest CT features, and CT-derived vascular metrics, we aimed to build a predictive model of in-hospital mortality using univariate analysis (Mann–Whitney U test) and machine learning models (support vectors machines (SVM) and multilayer perceptrons (MLP)). Patients with RT-PCR-confirmed SARS-CoV-2 infection and unenhanced chest CT performed on emergency department admission were included after retrieving their outcome (discharge or death), with an 85/15% training/test dataset spli…

Medicine (miscellaneous)X-ray computedtomography030204 cardiovascular system & hematologyMachine learningcomputer.software_genreArticlelung030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinepulmonary arterymedicine.arterymedicinesupport vector machinecomputerUnivariate analysisLungbusiness.industryRArea under the curveCOVID-19Emergency departmentneural networksmachine learningmedicine.anatomical_structureRadiological weaponPulmonary arteryMann–Whitney U testMedicineprognosisArtificial intelligenceTomographybusinesscomputerJournal of Personalized Medicine
researchProduct

Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER⁺ breast tumors.

2013

MEF2s transcription factors and class IIa HDACs compose a fundamental axis for several differentiation pathways. Functional relationships between this axis and cancer are largely unexplored. We have found that class IIa HDACs are heterogeneously expressed and display redundant activities in breast cancer cells. Applying gene set enrichment analysis to compare the expression profile of a list of putative MEF2 target genes, we have discovered a correlation between the down-regulation of the MEF2 signature and the aggressiveness of ER(+) breast tumors. Kaplan-Meier analysis in ER(+) breast tumors evidenced an association between increased class IIa HDACs expression and reduced survival. The im…

Mef2Nerve growth factor IBTranscription GeneticCell SurvivalApoptosisBreast NeoplasmsBiologyBiochemistryGene Expression Regulation EnzymologicHistone DeacetylasesTranscription (biology)BREAST CANCERCell Line TumorGeneticsNuclear Receptor Subfamily 4 Group A Member 1Gene silencingHumansGene SilencingMolecular BiologyPsychological repressionTranscription factorHDAC4BREAST CANCER; ERPrognosisNeoplasm ProteinsHDAC4; MEF2; BREAST CANCERGene Expression Regulation NeoplasticERMyogenic Regulatory FactorsReceptors EstrogenApoptosisCell cultureCancer researchFemaleMEF2BiotechnologyFASEB journal : official publication of the Federation of American Societies for Experimental Biology
researchProduct

Differential modulation and prognostic values of immune-escape genes in uveal melanoma

2019

Uveal melanoma (UM) is the most common primary intraocular cancer in adults. In the present study, we aimed to characterize the immunological features of primary UM cancer and to provide an association with prognostic markers and outcome. Also, we assessed the influence of the microenvironment on the expression of inhibitory immune checkpoints in UM. Genes of interest included MHC Class I and Class II molecules, as well as inhibitory immune-checkpoints, i.e. PDL1, PDL2, B7-H3, B7-H4, TBFRSF6B, CD47, CD155, GAL9, HVEM and CD200. We observed significant lower levels of MHC genes in UM cells as compared to normal uveal melanocytes. Unexpectedly however, the expression levels of most of the ana…

Melanomas0301 basic medicineUveal NeoplasmsGenetics and Molecular Biology (all)Gene ExpressionUveal NeoplasmPathology and Laboratory MedicineBiochemistryEpitheliumMetastasisMajor Histocompatibility ComplexWhite Blood Cells0302 clinical medicineAnimal CellsBiochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)Medicine and Health SciencesImmune ResponseMelanomaMultidisciplinarybiologyT CellsMelanomaQRPrognosisGene typesOncology030220 oncology & carcinogenesisMedicineMelanocytesCellular TypesAnatomyResearch ArticleHumanPrognosiScienceImmune CellsImmunologyMHC class I genesMajor histocompatibility complex03 medical and health sciencesSigns and SymptomsImmune systemMelanocyteDiagnostic MedicineMHC class IGeneticsmedicineHumansChromatophoresInflammationBlood CellsCancers and NeoplasmsBiology and Life SciencesCancerBiochemistry; Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)Epithelial CellsCell BiologyBiomarkermedicine.diseaseBiological Tissue030104 developmental biologyAgricultural and Biological Sciences (all)Cancer cellbiology.proteinCancer researchClinical ImmunologyClinical MedicineBiomarkers
researchProduct

Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome

2016

OBJECTIVE:The aim of this study was to evaluate over time circulating γδ T lymphocytes in melanoma patients in terms of frequency, effector functions, and relationship with clinical stage and evolution, by comparing preoperative values to those obtained at a mean follow-up of 36 months or in the event of recurrence or disease progression, and to those of healthy controls. Also, we correlated the presence of tumor-infiltrating γδ T lymphocytes with clinical evolution of melanoma. RESULTS:Mean frequencies of circulating γδ T cells before and after melanoma removal were very similar and comparable to healthy subjects, but patients who progressed to stage III or IV showed a significantly decrea…

MelanomasMale0301 basic medicineSkin NeoplasmsCellular differentiationmedicine.medical_treatmentSettore MED/19 - Chirurgia Plasticalcsh:MedicineWhite Blood Cells0302 clinical medicineAnimal CellsMedicine and Health SciencesMedicineCytotoxic T cellStage (cooking)lcsh:ScienceMelanomaγδ T lymphocytes melanoma prognostic biomarkerCultured Tumor CellsAged 80 and overMultidisciplinaryT CellsEffectorMelanomaCell DifferentiationReceptors Antigen T-Cell gamma-deltaMiddle AgedPrognosisPhenotypeSurgical OncologyPhenotypeCytokineOncology030220 oncology & carcinogenesisCutaneous MelanomaMelanoma CellsFemaleImmunotherapyBiological CulturesCellular TypesResearch ArticleAdultDeath RatesImmune CellsImmunologyMalignant Skin NeoplasmsSurgical and Invasive Medical ProceduresDermatologyResearch and Analysis Methods03 medical and health sciencesLymphocytes Tumor-InfiltratingPopulation MetricsHumansDemographyAgedNeoplasm StagingSettore MED/04 - Patologia GeneraleBlood CellsPopulation Biologybusiness.industrylcsh:RCase-control studyBiology and Life SciencesCancers and NeoplasmsCell BiologyCell Culturesmedicine.disease030104 developmental biologyCase-Control StudiesPeople and PlacesImmunologylcsh:QClinical ImmunologyClinical MedicinebusinessPLOS ONE
researchProduct

A Brief Synopsis on Scalp Melanoma

2020

Melanoma constitutes one of the most sinister and troublesome malignancies encountered by humanity. Generally, the diagnosis of advanced melanoma connotes a grave prognosis, prompting a sense of looming threat of death, however, the early-stage detected disease responds well to robust treatment resulting in reasonable survivorship. Scalp melanomas are even more troublesome, because they typically exhibit more aggressive biologic behavior and are often diagnosed at a late stage. This review tries to comprehensively highlight the various diagnostic, therapeutic, and outcome aspects of scalp melanomas. The literature research includes peer-reviewed articles (clinical trials or scientific revie…

Melanomasmedicine.medical_specialtySkin NeoplasmsMEDLINEDermatologyEnglish languageDiseaseBreslow thickness; head and neck melanomas; melanomas; scalp melanomas; skin malignancies; Humans; Prognosis; Scalp; Head and Neck Neoplasms; Melanoma; Skin NeoplasmsBreslow thickne030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineHumansMelanomaScalp melanomaAdvanced melanomaScalpHead and neck melanomabusiness.industryMelanomaLate stageHead and neck melanomasGeneral MedicinePrognosismedicine.diseaseDermatologyBreslow thickness; Head and neck melanomas; Melanomas; Scalp melanomas; Skin malignanciesClinical trialmedicine.anatomical_structureScalp melanomasHead and Neck NeoplasmsSkin malignancies030220 oncology & carcinogenesisScalpbusinessBreslow thickness
researchProduct

Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential bi…

2017

Background Malignant Pleural Mesothelioma (MPM) is an aggressive cancer mainly caused by asbestos exposure and refractory to current therapies. Specific diagnostic markers for early MPM diagnosis are needed. Changes in miRNA expression have been implicated in several diseases and cancers, including MPM. We examined if a specific miRNA signature in plasmatic extracellular vesicles (EV) may help to discriminate between malignant pleural mesothelioma patients (MPM) and subjects with Past Asbestos Exposure (PAE). Methodology/Principal findings We investigated 23 MPM patients and 19 cancer-free subjects with past asbestos exposure (PAE). We screened 754 miRNAs in plasmatic EVs by OpenArray and f…

MesotheliomaMalePhysiologyPleural Neoplasmslcsh:MedicineBiochemistryLung and Intrathoracic TumorsBlood PlasmaDiagnostic MedicineGeneticsMedicine and Health SciencesCancer Detection and DiagnosisBiomarkers TumorHumansVesiclesNon-coding RNAlcsh:ScienceAgedBiology and life scienceslcsh:RCancers and NeoplasmsAsbestosCell BiologyMiddle AgedPrognosisGene regulationBody FluidsNucleic acidsMicroRNAsBloodOncologyRNAFemalelcsh:QGene expressionCellular Structures and OrganellesAnatomyBiomarkersResearch ArticlePLoS ONE
researchProduct